The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.

A large genetic study reveals depression beginning in young adulthood has a stronger hereditary component and a much greater ...

Tea (Camellia sinensis) is one of the world's most widely consumed beverages, and the size of young buds directly influences ...

Mosquito-borne diseases, including dengue, Zika, and yellow fever, continue to pose a significant global health threat, ...

Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

吉隆坡/新加坡 - BioNexus Gene Lab Corp.（纳斯达克代码：BGLC） 周三宣布，已与Fidelion Diagnostics和通舒生物科技 (音译) (Tongshu Biotechnology)签订最终协议，共同商业化VitaGuard液体活检平台，用于微小残留病灶 (MRD)检测。这家市值仅925万美元的微型市值公司，尽管交易波动较大，但其股价自年初至今已上涨84%。